文献速递分子诊断临床微生物

应用锁定核酸与引物悬垂的先进分子脊髓灰质炎病毒诊断技术在多实时PCR平台上的表现

Advanced molecular poliovirus diagnostics across multiple real-time PCR platforms with locked nucleic acids and primer overhangs.
PubMed 文献 · J Clin Microbiol · 2026-09-16

本研究开发并验证了五种实时RT-PCR assay,用于脊髓灰质炎病毒型内鉴别和疫苗衍生脊髓灰质炎病毒 discrimination,采用锁定核酸(LNA)和引物悬垂技术。更新后的 assay 包括野生型1/Qβ双工、VDPV1和3、野生型3及新型口服脊髓灰质炎2型,由CDC脊髓灰质炎和微小RNA病毒分支主导,在多个实时PCR平台上验证,并在中亚和非洲暴发地区参考实验室试点。结果显示引物悬垂增强荧光、提高弱信号解读,VDPV3分析灵敏度提升10至100倍,对已灭绝WPV3检测灵敏度100%特异性96.97%,循环基因型WPV1灵敏度100%特异性98.72%,nOPV2与Sabin 2区分特异性100%。

要点

  • LNA与引物悬垂技术提升弱信号解读和VDPV3分析灵敏度10-100倍。
  • 新assay可靠检测已灭绝WPV3和循环WPV1,并区分Sabin 1/3与疫苗衍生株。
  • nOPV2与Sabin 2区分特异性100%,支持全球脊髓灰质炎监测。

核心结论

  • 五种实时RT-PCR assay结合LNA和引物悬垂技术,提高了脊髓灰质炎病毒分子诊断的灵敏度和特异性,支持全球消灭脊髓灰质炎监测。

研究设计与样本

  • 由CDC脊髓灰质炎和微小RNA病毒分支主导开发五种实时RT-PCR assay,使用涵盖三个血清型、非脊髓灰质炎肠道病毒和疫苗种子株的病毒集合进行验证,并在中亚和非洲暴发地区参考实验室试点。

主要发现

  • 引物含AT-rich悬垂增强荧光,改善VDPV1和WPV1 assay弱信号解读,VDPV3 assay分析灵敏度提升10至100倍(100%)。
  • 新assay检测已灭绝WPV3灵敏度100%特异性96.97%,检测循环基因型WPV1灵敏度100%特异性98.72%。
  • 可区分Sabin 1和3与疫苗衍生株,区分nOPV2与Sabin 2特异性100%。

关键数值与推荐

  • VDPV3 assay分析灵敏度提升10至100倍(100%)。
  • 已灭绝WPV3检测灵敏度100%特异性96.97%。
  • 循环基因型WPV1检测灵敏度100%特异性98.72%。
  • nOPV2与Sabin 2区分特异性100%。

临床怎么用

  • 新assay可用于脊髓灰质炎病毒型内鉴别和疫苗衍生病毒区分,适配多种实时PCR平台,支持废水和粪便样本监测。

局限性

  • 灭绝脊髓灰质炎病毒获取受限,阻碍诊断实验室设计和验证实时RT-PCR assay;目前无商业检测可检测并分型所有脊髓灰质炎病毒血清型。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: This study details the development and validation of five real-time RT-PCR assays for the intratypic differentiation (ITD) of polioviruses and the discrimination of vaccine-derived polioviruses (VDPVs) utilizing locked nucleic acid (LNA) technology and primer overhangs. Updated assays, including wild-type 1/Qβ duplex (WPV1), VDPVs 1 and 3, wild-type 3, and novel oral poliovirus type 2 (nOPV2), were designed in response to challenges posed by genetic diversity and detection gaps in existing protocols following outbreaks, and the introduction of a new vaccine replacing the Sabin 2 oral poliovirus vaccine (OPV). The CDC's Polio and Picornavirus Branch led assay development, supporting global surveillance efforts with kits tailored for use across multiple real-time PCR platforms. Comprehensive virus collections representing all three poliovirus serotypes, nonpolio enteroviruses, and vaccine seed strains were used in the validation. Assay performance was assessed through piloting in poliovirus reference laboratories across outbreak regions, including Central Asia and Africa. Combining primers with AT-rich overhangs enhanced fluorescence, improving interpretation of weak signals for VDPV1 and WPV1 assays, and boosting analytical sensitivity for the VDPV3 assay by 10-fold to 100-fold (100%). The new assays enabled reliable detection of extinct WPV3 (100% sensitivity and 96.97% specificity), the circulating genotype WPV1 (100% sensitivity and 98.72% specificity), and discrimination of Sabin 1 and 3 from vaccine-derived strains, and the discrimination of nOPV2 from Sabin 2 (100% specificity) from surveillance samples. These advancements mark a significant milestone in molecular diagnostics for poliovirus eradication, supporting surveillance and response efforts worldwide, with remaining pockets of circulating VDPVs and wild-type 1 viruses. IMPORTANCE: Recent poliovirus detections from wastewater in non-endemic regions sparked renewed interest in the agent. Limited access to extinct polioviruses for validation studies hinders diagnostic laboratories from designing and validating real-time RT-PCR assays for specific and sensitive detection in wastewater or stools. There are currently no commercial tests that can detect and type all poliovirus serotypes that have been assessed with recent endemic or seed viruses used by vaccine manufacturers, making the intratypic differentiation unique. This work describes the redesign and validation of the five RT-PCR assays with various poliovirus strains such as vaccine seed strains, outbreak strains, and eradicated viruses. Locked nucleic acids and primer overhangs were applied to the primer and probe design, resulting in advanced laboratory capability to detect contemporary poliovirus strains, strengthening surveillance in support of the global poliovirus eradication activities.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Gerloff N, Sun H, Short B, et al. Advanced molecular poliovirus diagnostics across multiple real-time PCR platforms with locked nucleic acids and primer overhangs. J Clin Microbiol. 2026. PMID: 42747277. doi:10.1128/jcm.00658-26

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。